Loading clinical trials...
Loading clinical trials...
UAB 2507 - Randomized Phase II Study of Differential Margins in Single Isocenter Radiosurgery of Brain Metastases
Conditions
Interventions
brain metastases radiosurgery
Locations
1
United States
University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center
Birmingham, Alabama, United States
Start Date
April 8, 2025
Primary Completion Date
June 1, 2028
Completion Date
August 1, 2028
Last Updated
October 15, 2025
NCT05692635
NCT07464470
NCT05987644
NCT05419076
NCT05139277
NCT04923542
Lead Sponsor
University of Alabama at Birmingham
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions